Open AccessValidation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis
Author(s) -
Atsushi Hiraoka,
Takashi Kumada,
Kiichiro Tsuji,
Koichi Takaguchi,
Ei Itobayashi,
Kazuya Kariyama,
Hironori Ochi,
Kazuto Tajiri,
Masashi Hirooka,
Noritomo Shimada,
Toru Ishikawa,
Yoshihiko Tachi,
Toshifumi Tada,
Hidenori Toyoda,
Kazuhiro Nouso,
Kouji Joko,
Yoichi Hiasa,
Kojiro Michitaka,
Masatoshi Kudo
Publication year - 2018
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000488778
Subject(s) - hepatocellular carcinoma , medicine , gastroenterology , liver function , stage (stratigraphy) , paleontology , biology
The frequency of hepatocellular carcinoma (HCC) in patients with good hepatic reserve function has been increasing in Japan along with the progression of antiviral therapies and aging of the society. We evaluated the usefulness of modified albumin-bilirubin (ALBI) grade as a tool for assessment of hepatic reserve function.